South Korea has unveiled a set of regulatory innovation measures designed to foster the biopharma industry, particularly new vaccines and technologies, by boosting investment, speeding up processes, aligning with global standards and adopting systems appropriate for the latest technologies.
Korea’s Regulatory Innovation Steps Focus On Investment, New Technologies
Faster Approvals, Better Competitiveness Eyed
South Korean ministries release comprehensive broad steps under new government aimed at accelerating investment to deal with infectious diseases and supporting regulatory innovation, including speeding up processes, to match global standards, support new technologies and improve access.
